10/04/2025 09:37

Pro Medicus Ltd (PME) $188.14

We have discussed health imaging technology company PME several times in recent months, delivering the same message: it's an exciting growth stock but too expensive.

Read more

01/04/2025 09:30

Pro Medicus Ltd (PME) $199.79

Read more

27/02/2025 09:20

Pro Medicus Ltd (PME) $273.19

Recently, we have seen several high-flying stocks pullback after reporting, even after delivering solid reports,  the market was priced for more and crowded momentum trades can often produce sharp corrections, especially at the pointy end of town where valuations are lofty:

Read more

13/02/2025 16:54

Pro Medicus Ltd (PME) $279.78

PME -3.2%: We saw it recently with JB Hi-Fi (JBH) and CAR Group (CAR),  a stock priced for “perfection” needs to knock it out of the proverbial park when it reports, or profit-taking follows, especially at the pointy end of town in terms of valuations and how crowded the position has become.

Read more

13/02/2025 09:27

Pro Medicus Ltd (PME) $288.31

This is undoubtedly a great business, but a few quiet months in terms of new deals could easily see another $25-30 pullback. We’ve already witnessed three in less than 18 months. MM has written this a bit lately, but we don’t like the risk/reward towards PME into new highs.

Read more

04/12/2024 09:34

First Up

After yesterday's close, China Investment Corporation (CIC) launched a massive $1.9 billion selldown of market darling Goodman Group (GMG). Citi’s equities desk was looking to place 50.4 million GMG shares or about 2.6% of the company; to put things into perspective, only 3.7 million shares exchanged hands on Tuesday.

Read more

28/11/2024 16:48

Pro Medicus (PME) $248.18

PME +8.66%: The medical imaging company signed a A$330m deal with U.S hospital operator Trinity Health to replace legacy Picture Archiving and Communication Systems (PACS) over a 10-year period.

Read more

15/08/2024 09:26

Pro Medicus Ltd (PME) $141.00

PME surged over +7% on Wednesday, back towards its all-time high, following a sold FY24 result that beat across all metrics. Chief executive Sam Hupert said he remained confident in the company’s medical imaging software, assuring investors its stellar run is far from over as it eyes new revenue streams from cardiology and artificial intelligence. However, he understandably cautioned that it will be unable to deliver +30% annual profit growth forever.

Read more

07/08/2024 09:34

Pro Medicus Ltd (PME) $123.00

Medical imaging software provider PME has been enjoying solid success, which has contributed to the stock's +28% advance year-to-date, even after the 15% decline over the last fortnight. For subscribers not familiar with PME, it's now a $12bn business that generates revenue from software used in medical imaging practices made up of a subscription fee plus a small fee charged per each medical image done on its platform.

Read more

27/06/2024 09:54

Pro Medicus Ltd (PME) $135.98

We have been bullish but too conservative towards PME through 2024, but this medical software business is going from strength to strength; it’s the sector standout this year, advancing over 45% year-to-date. The stock is ridiculously expensive on today's numbers, but its valuation will fall over the coming years if earnings growth continues as its impressive pace. From a risk/reward perspective, ideally, we like PME ~$135, less than 5% lower.

Read more